Treatment Approaches for TP53-Mutated AML | OncLive
Treatment Approaches for TP53-Mutated AML | OncLive
6 days ago
onclive.com
FLT3-Mutated AML: Early Aggressive Therapy vs Transplant | OncLive
FLT3-Mutated AML: Early Aggressive Therapy vs Transplan…
1 week ago
onclive.com
Frontline Treatment in Patients With IDH-Mutated AML Unfit for Intensive Chemotherapy | OncLive
Frontline Treatment in Patients With IDH-Mutated AML Unfit for Intensi…
Feb 28, 2023
onclive.com
Understanding Anti-Money Laundering (AML): Key Processes and Global Impact
Understanding Anti-Money Laundering (AML): Key Processe…
5 months ago
investopedia.com
Activity, Tolerability and Resistance Profile of the Menin Inhibitor Ziftomenib in Adults With Relapsed or Refractory NPM1-Mutated AML
Activity, Tolerability and Resistance Profile of the Menin Inhibitor Zifto…
Jul 12, 2023
onclive.com
Unmet Needs for Patients With AML | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Unmet Needs for Patients With AML | Targeted Oncology - Immunother…
Jan 3, 2024
targetedonc.com
Phase 1b Study of Azacitidine, Venetoclax and Revumenib in Newly Diagnosed Older Adults with NPM1 Mutated or KMT2A Rearranged AML: Interim Results of Dose Escalation from the Beat AML Consortium | OncLive
13:50
Phase 1b Study of Azacitidine, Venetoclax and Revumenib in Ne…
2 weeks ago
onclive.com
Understanding the NPM1 Mutation in AML: Dr. Jekyll and Mr. Hyde
632 viewsJul 11, 2024
vumedi.com
What is New in AML: Risk Classification, Germline Mutations…
349 viewsMay 29, 2024
vumedi.com
Retesting for FLT3 Mutation Status in AML | OncLive
Jul 9, 2019
onclive.com
Dr Fedorov on the Use of Quizartinib vs Midostaurin in FLT3 AML | Onc…
Apr 26, 2024
onclive.com
Treatment Options for AML Patients with IDH2, RUNX1, or DNMT3A Mu…
Aug 8, 2022
targetedonc.com
1:57
Ziftomenib with azacitidine and venetoclax in NPM1-mutated AML…
35 views1 month ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:59
KOMET-007: ziftomenib in combination with venetoclax and …
19 views1 month ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:30
KOMET-001 Study Design: Which Led to the FDA approval of Ziftom…
300 views2 months ago
YouTubeOncology Brothers Clips
5:56
Treating AML
68.1K viewsNov 27, 2019
YouTubeYou and AML
6:35
Understanding AML
171.7K viewsDec 2, 2019
YouTubeYou and AML
Azacitidine, venetoclax & gilteritinib in older/unfit patients with FLT3-m…
728 viewsJun 20, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
Scientists Reveal 51 Mutations Linked to Changes in ALS Risk | C…
Nov 3, 2024
labroots.com
Dr. Röllig on FLT3 ITD/NPM1 Mutation Status for Patients With …
1.4K viewsSep 21, 2015
YouTubeTargeted Oncology
AML-MR mutations drive the benefit of CPX-351 over 7+3 in the pivotal …
89 views11 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
MRD negativity in NPM1-mutated AML: the influence of co-occurrin…
171 viewsDec 13, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
Secondary-type mutations do not impact the favorable prognosis in …
319 viewsFeb 21, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
7:02
Acute Myeloid Leukemia (AML)
21K viewsAug 25, 2013
YouTubeNEJM Group
1:27
What Is AML?
23.1K viewsApr 19, 2018
YouTubeBlood Cancer United
4:28
Understanding Myelodysplastic Syndromes (MDS)
72K viewsJul 27, 2018
YouTubeYou and MDS
5:38
Understanding AML-MRC and tAML
9.6K viewsNov 27, 2019
YouTubeYou and AML
7:45
Diagnosing AML, AML-MRC, and tAML
8.6K viewsNov 27, 2019
YouTubeYou and AML
2:05
Expanded treatment options for Acute Myeloid Leukemia (AML)
22.4K viewsDec 10, 2018
YouTubeDana-Farber Cancer Institute
3:42
Midostaurin in c-KIT or FLT3-ITD mutated t(8;21) AML
883 viewsJun 30, 2020
YouTubeVJHemOnc – Video Journal of Hematology & H…
See more videos
Static thumbnail place holder